223 related articles for article (PubMed ID: 36969076)
1. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q
Front Oncol; 2023; 13():1077309. PubMed ID: 36969076
[TBL] [Abstract][Full Text] [Related]
2. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients.
Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q
Front Genet; 2022; 13():862210. PubMed ID: 35903358
[No Abstract] [Full Text] [Related]
3. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy.
Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P
Front Oncol; 2022; 12():1024956. PubMed ID: 36439501
[TBL] [Abstract][Full Text] [Related]
4. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.
Sun Y; Xu Y; Che X; Wu G
Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357
[TBL] [Abstract][Full Text] [Related]
5. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
Yu J; Mao W; Xu B; Chen M
Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
[TBL] [Abstract][Full Text] [Related]
6. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
[TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
9. A 9-gene prognostic signature for kidney renal clear cell carcinoma overall survival based on co-expression and regression analyses.
Zhu W; Ding M; Chang J; Liao H; Xiao G; Wang Q
Chem Biol Drug Des; 2023 Feb; 101(2):422-437. PubMed ID: 36053927
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
Front Genet; 2020; 11():568192. PubMed ID: 33133154
[TBL] [Abstract][Full Text] [Related]
11. Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma.
Xin S; Sun X; Jin L; Zhou Z; Liu X; Li W; Mei W; Zhang J; Zhang B; Yao X; Zhou L; Ye L
J Oncol; 2022; 2022():9498010. PubMed ID: 35342405
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma.
Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L
Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662
[TBL] [Abstract][Full Text] [Related]
14. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.
Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X
J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648
[TBL] [Abstract][Full Text] [Related]
15. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance, immune infiltration, and tumor mutational burden of angiogenesis-associated lncRNAs in kidney renal clear cell carcinoma.
Zhang W; Liu Z; Wang J; Geng B; Hou W; Zhao E; Li X
Front Immunol; 2022; 13():934387. PubMed ID: 35958561
[TBL] [Abstract][Full Text] [Related]
17. Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms.
Wang Y; Liu S; Chen Y; Zhu B; Xing Q
World J Oncol; 2022 Feb; 13(1):27-37. PubMed ID: 35317332
[TBL] [Abstract][Full Text] [Related]
18. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
Zhao YW; Ma W; Jiang F; Xie Y; Tang L
Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
Jiang H; Chen H; Wan P; Chen N
Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
